| 000 | 02666nam a2200409 i 4500 | ||
|---|---|---|---|
| 999 |
_c12360 _d12360 |
||
| 001 | 12360 | ||
| 003 | ES-MaUEC | ||
| 005 | 20211130040342.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn nnnaamaa | ||
| 008 | 200708s2020 gw a o |||| 0|eng d | ||
| 020 | _a9783030586508 | ||
| 024 | 7 |
_a10.1007/978-3-030-58650-8 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aRM375 _b.R46 2021 EB |
|
| 100 |
_9517711 _aGolightly, Larry K. |
||
| 245 | 0 | 0 |
_aRenal Pharmacotherapy: _bDosage Adjustment of Medications Eliminated by the Kidneys _cLarry K. Golightly, Isaac Teitelbaum, Bonita A. Simendinger, Tyree H. Kiser, Gerard R. Barber, Nancy M. Stolpman |
| 250 | _a2nd ed. 2021 | ||
| 264 | 1 |
_aCham _bSpringer Nature Switzerland _c2021 |
|
| 300 |
_a1 recurso en línea (XXVI, 827 páginas) _b2 ilustraciones, 0 ilustraciones a color |
||
| 336 |
_2rdacontent _aTexto _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_aArchivo de texto _bPDF |
||
| 490 | 0 | _aMedicine (Springer-11650) | |
| 520 | _aTo promote effectiveness and minimize possible toxicity, the dosage of certain medications must be adjusted in persons with compromised kidney function. Failure to enjoin appropriate dosage adjustments in patients with abnormal or rapidly changing kidney function continues to lead to reports of drug toxicity involving a broad array of renally eliminated medications. This updated edition captures nearly 200 new drugs that have been approved by the FDA since the initial publication of Renal Pharmacotherapy. It also covers new evidence that has emerged regarding the need to adjust dosage of certain older medications that are eliminated by the kidneys. Additionally, it presents new data that are being continuously derived in the areas of patient-specific dose individualization for drugs of all types. Comprehensive, convenient, and evidence-based, this reference closes several identified knowledge gaps and will continue to be the leading collection of dosage recommendations for patients with compromised kidney function. | ||
| 650 | 7 |
_2embne _9669379 _aRiñones |
|
| 650 | 7 |
_2embne _aFarmacología _9137893 |
|
| 700 |
_aTeitelbaum, Isaac _9517712 |
||
| 700 |
_aSimendinger, Bonita A. _9517713 |
||
| 700 |
_aKiser, Tyree H. _9517714 |
||
| 700 |
_aBarber, Gerard R. _9517715 |
||
| 700 |
_aStolpman, Nancy M. _9517716 |
||
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-58650-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Valencia) |
| 942 |
_2lcc _cLE |
||
| 998 |
_db _zSI |
||